Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCLI | AZN | AMGN | GILD | BMY |
| Company | Brainstorm Cell Theraputc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9100 | 187.67 | 350.76 | 139.76 | 57.79 |
| High | 0.9619 | 188.72 | 358.00 | 140.42 | 59.39 |
| Low | 0.9100 | 186.44 | 350.76 | 137.92 | 57.79 |
| Latest | 0.9100 | 187.14 | 353.93 | 138.26 | 58.94 |
| Change | +0.0200 | +1.36 | +5.50 | +0.15 | +1.55 |
| % Change | +2.25% | +0.73% | +1.58% | +0.11% | +2.70% |
| Volume | 16,843 | 1,480,713 | 1,706,409 | 5,044,124 | 9,041,299 |
| 20-Day Average Volume | 23,158 | 1,851,410 | 2,706,111 | 6,670,829 | 14,577,476 |
| Previous Close | 0.8900 | 185.78 | 348.43 | 138.11 | 57.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7756 | 193.90 | 366.93 | 144.10 | 59.84 |
| 20-Day Raw Stochastic | 88.00% | 16.81% | 17.99% | 11.44% | 37.37% |
| 20-Day Relative Strength | 66.18 | 43.13 | 45.51 | 43.63 | 50.55 |
| Weighted Alpha | +19.96 | +27.40 | +19.11 | +26.10 | +9.48 |
| Today's Opinion | 72% Buy | 56% Buy | 56% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 56% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 32% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.43% since 03/18/26 | -0.74% since 03/18/26 | +0.51% since 03/18/26 | -2.27% since 03/18/26 | -0.87% since 03/18/26 |
| Low | 0.8003 on 03/23/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 0.9699 on 03/24/26 | 189.79 on 03/19/26 | 358.00 on 03/25/26 | 142.09 on 03/19/26 | 59.64 on 03/19/26 |
| 1-Month | |||||
| %Chg | +48.39% since 02/25/26 | -9.12% since 02/25/26 | -8.08% since 02/25/26 | -6.14% since 02/25/26 | -3.99% since 02/25/26 |
| Low | 0.5950 on 02/26/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 0.9699 on 03/24/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +56.76% since 12/24/25 | +1.15% since 12/24/25 | +5.79% since 12/24/25 | +9.88% since 12/24/25 | +7.58% since 12/24/25 |
| Low | 0.4589 on 02/13/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.9699 on 03/24/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +32.13% since 09/25/25 | +27.17% since 09/25/25 | +30.28% since 09/25/25 | +24.41% since 09/25/25 | +35.58% since 09/25/25 |
| Low | 0.4589 on 02/13/26 | 146.66 on 09/26/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.9699 on 03/24/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,821 | 288,127,680 | 187,827,456 | 171,425,184 | 116,873,240 |
| Shares Outstanding, K | 11,035 | 1,550,908 | 539,068 | 1,241,222 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,620,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,110,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.69 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.91 on 11/14/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/30/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.09 | 16.01 | 16.85 | 9.27 |